Taketoshi Kato

Prostaglandin D2, a potential antineoplastic agent

Masanori Fukushima, Taketoshi Kato, Ryuzo Ueda et al. · Biochemical and Biophysical Research Communications · 1982 · 112 citations

Medicine, Pathology, Pharmacotherapy +4

9-Deoxy-Δ9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activities

Masanori Fukushima, Taketoshi Kato, Kazuo Ota et al. · Biochemical and Biophysical Research Communications · 1982 · 93 citations

Molecular Pharmacology, Molecular Physiology, Biochemistry +5

A comparative study on cytotoxicities and biochemical properties of anthraquinone mycotoxins emodin and skyrin from Penicillium islandicum sopp

Kiyoshi Kawai, Taketoshi Kato, Hideki Mori et al. · Toxicology Letters · 1984 · 53 citations

Antifungal Agent, Biochemistry, Mycotoxin Formation +7

Elevation of serum lipid peroxide level associated with doxorubicin toxicity and its amelioration by [dl]-?-tocopheryl acetate or coenzyme Q10 in mouse (doxorubicin, toxicity, lipid peroxide, tocopherol, coenzyme Q10)

Naoki Yamanaka, Taketoshi Kato, Keiko Nishida et al. · Cancer Chemotherapy and Pharmacology · 1979 · 33 citations

Inflammation, Doxorubicin Toxicity, Oxysterol +12

Mechanistic aspects of the cytocidal action of ulithiacyclamide on mouse leukemia L1210 cells in vitro

Kohda Kohfuku, Yuko Ohta, Yokoyama Yumi et al. · Biochemical Pharmacology · 1989 · 30 citations

Medicine, Cytocidal Action, Mechanistic Aspects +4